Antitrust Policy in Health Care Markets

Préface
Explains how monopoly and monopsony contribute to soaring health care costs in the US and explores antitrust remedies.

Auteur

Roger D. Blair is Professor of Economics at the University of Florida.

Résumé
This book is aimed at anyone who is concerned about the lack of competition in health care markets and the steadily rising cost of health care in the United States. It integrates principles of economics and antitrust policy to explain how monopoly and monopsony contribute to soaring health care costs in the US and explores antitrust remedies.

Contenu

1. Health care markets and competition policy; 2. Antitrust policy in the United States; Section I. Monopoly: 3 Patents and monopoly pricing of pharmaceuticals; 4. Patents and exclusionary product hopping; 5. Bundled discounts and peace health; Section II. Seller Cartels: 6. Collusion in health care markets; 7. Collusion in generic drug markets; 8. The hatch-waxman act, patent infringement suits, and reverse payments; Appendix; The economics of settlements; 9. The alleged insulin conspiracy; 10. Licensing of health care professionals; Section III. Monopsony: 11. Monopsony, dominant buyers, and oligopsony; 12. Countervailing power - physician collective bargaining; 13. Group purchasing organizations, monopsony, and antitrust policy; Section IV. Buyer Cartels: 14. Collusion in the nurse labor market; 15. Collusion in the oocyte market; 16. No-Poaching agreements and antitrust policy; Section V. Mergers and Acquisitions: 17. The economics of horizontal mergers; 18. Horizontal merger policy; 19. The economic theory of vertical integration; 20. Vertical merger policy; 21. Concluding remarks.